Impulse control disorder and piribedil: Report of 5 cases

Clinical Neuropharmacology

Volumn 33, Issue 1, 2010, Pages 11-13

  Tschopp, Lorena ^a   Salazar, Zulema ^a   Gomez Botello, Marco T ^a   Roca, Claudia Uribe ^a   Micheli, Federico ^a  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

Impulse control disorder; Multiple system athrophy; Parkinson; Piribedil

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; CABERGOLINE; CARBIDOPA PLUS LEVODOPA; DONEPEZIL; LEVODOPA; LEVOTHYROXINE; MEMANTINE; PIRIBEDIL; PRAMIPEXOLE; QUETIAPINE;

ADD ON THERAPY; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BEHAVIOR DISORDER; BRADYKINESIA; BRAIN ATROPHY; CLINICAL ARTICLE; COMPULSION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSARTHRIA; FEMALE; GAIT DISORDER; HAND TREMOR; HUMAN; HYPERSEXUALITY; HYPOTHYROIDISM; IMPULSE CONTROL DISORDER; INTERNET ADDICTION; JEALOUS DELUSION; LEG EDEMA; LEUKOARAIOSIS; LIMB TREMOR; MALE; MUSCLE RIGIDITY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERNUTRITION; PARKINSON DISEASE; PARKINSONISM; PATHOLOGICAL GAMBLING; POLYSOMNOGRAPHY; PRIORITY JOURNAL; REHABILITATION CARE; SEXUAL DYSFUNCTION; SHY DRAGER SYNDROME; SLEEP APNEA SYNDROME; THALAMOTOMY; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL HALLUCINATION;

AGED; DOPAMINE AGONISTS; FEMALE; HUMANS; IMPULSE CONTROL DISORDERS; MALE; MIDDLE AGED; PARKINSON DISEASE; PIRIBEDIL; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX;

EID: 76749171646     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e3181c4ae2e     Document Type: Article

References (29)

1. Antonini A, Cilia R. Behavioural adverse effects of dopaminergic treatments in Parkinson's disease: incidence, neurobiological basis, management and prevention. Drug Saf 2009;32.6:475-488.
2. Grosset K Problematic gambling on dopamine agonists: not such a rarity. Mov Disord 2006;21(12):2206-2208.
3. Dodd ML. Pathological gambling caused b- drugs used to treat Parkinson's disease Arch Neurol 2005;62:1-5.
4. Voon V. Prospective prevalence of pathologic gambling and medication association in Parkinson Disease. Neurolog- 2006;66: 1750-1752
5. O'Sullivan SS, Evans AH, Lees AJ. Dopamine d-sregulation syndrome: an overview of its epidemiology, mechanisms and management CNS Drugs 2009;23.2:157-170.
6. Tippmann-Peikert M, Park JG, Boeve BF, et al. Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists. Neurology 2007;68(4):301-303.
7. Evans AH, Butzkueven H. Dopamine agonist-induced pathological gambling in restless legs s-ndrome due to multiple sclerosis Mov Disord 2007;22.4:590-591.
8. Wong S. Parkinsonism and impulse control disorder: presentation of a new progranulin gene mutation. Mov Disord 2009;24(4):617-628.
9. Holman AJ. Impulse control disorder behaviors associated with pramipexole used to treat fibromyalgia. J Gambl Stud 2009;25(3):425-431.
10. Pontone G. Clinical features associated with impulse control disorders in Parkinson disease. Neurolog- 2006;67:1258-1261
11. Weintraub D. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 2006;63:969-973.
12. Voon V Factors associated with dopamine drug-related pathological gambling in Parkinson's disease. Arch Neurol 2007;64:212-216.
13. Klos KJ Pathological h-persexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy Parkinsonism Relat Disord 2005;11:381-386.
14. Shapiro MA. H-persexuality and paraphilia induced by selegiline in Parkinson' s disease: report of 2 cases Parkinsonism Relat Disord 2006;12:392-395.
15. Nirenberg MJ. Compulsive eating and weight gain related to dopamine agonist use. Mov Disord 2006;21(4):524-529.
16. Evans AH. Factors influencing susceptibilit- to compulsive dopaminergic drug use in Parkinson disease Neurology 2005;65: 1570-1574.
17. Ferreira Garcia R. Treatment of juvenile Parkinson disease and the recurrent emergence of pathologic gambling. Cogn Behav Neurol 2007;20:11-14.
18. Voon V. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurolog- 2006;67:1254-1257
19. Avanzi M. Prevalence of pathological gambling in patients with Parkinson's disease. Mov Disord 2006;21(12):2068-2072.
20. Giovannoni G, O'Sullivan JD, Turner K, et al. Hedonistic homeostatic d-sregulation in patients with Parkinson's disease on dopamine replacement therapies J Neurol Neurosurg Psychiatry 2000;68:423-428. (Pubitemid 30248740)
21. Evans AH. Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Mov Disord 2004;19(4):397-405.
22. Mimura M. Impaired decision-making in Parkinson's disease. Parkinsonism Relat Disord 2006;12:169-175.
23. Evans AH. Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson's. J Neurol Neurosurg Ps-chiatry 2006;77:317-321
24. Imamura A. Dopamine agonist therap- for Parkinson disease and pathological gambling Parkinsonism Relat Disord 2006;12:506-508.
25. Lader M. Antiparkinsonian medication and pathological gambling. CNS Drugs 2008;22(5):407-416.
26. Molina JA, Sáinz-Artiga MJ, Fraile A, et al. Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment? Mov Disord 2000;15.5:869-872.
27. Driver-Dunckle- E Pathological gambling associated with dopamine agonist therapy in Parkinson' Disease. Neurology 2003;61:422-423.
28. Merims D, Giladi N. Dopamine d-sregulation syndrome, addiction and behavioral changes in Parkinson's disease Parkinsonism Relat Disord 2008;14.4:273-280.
29. Rascol O, Dubois B, Caldas AC, et al. Earl- piribedil monotherapy for Parkinson's disease: a planned seven-month report of the REGAIN study Mov Disord 2006;21.12:2110-2115.